Cm Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Cm Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$1.33 - $3.1 $166,250 - $387,500	125,000 Added 83.33%	275,000 $853,000
Q3 2022 Nov 04, 2022	BUY	$2.02 - $3.62 $101,000 - $181,000	50,000 Added 50.0%	150,000 $303,000
Q2 2022 Aug 08, 2022	BUY	$3.01 - $4.46 $301,000 - $446,000	100,000 New	100,000 $318,000
Q1 2021 May 12, 2021	SELL	$4.74 - $7.38 $592,500 - $922,500	-125,000 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$3.95 - $5.42 $493,750 - $677,500	125,000 New	125,000 $571,000

183

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.21B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.